Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases

摘要

BackgroundSince 2006, human papillomavirus (HPV) vaccines have been introduced in many countries worldwide. Whilst safety studies have been reassuring, focus has been on the primary target group, the young adolescent girls. However, it is also important to evaluate safety in adult women where background disease rates and safety issues could differ significantly.